ARBEL IRIT 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Feb 14, 2020
Insider Transaction Report
Form 4
ARBEL IRIT
Director
Transactions
- Award
Stock Option (right to buy)
2019-12-12+25,333→ 25,333 totalExercise: $0.75From: 2020-01-12Exp: 2029-12-12→ Common Stock (25,333 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on January 12, 2020 until fully vested and exercisable on December 12, 2020, provided that the reporting person remains a director (and committee member, as applicable) of Brainstorm Cell Therapeutics on each vesting date.